Currently out of the existing stock ratings of Gobind Singh, 14 are a BUY (93.33%), 1 are a HOLD (6.67%).
Analyst Gobind Singh, has had 58.33% of price targets met with an average potential upside of 52.66%, reached in 389 days on average. Previously, Gobind Singh worked at HC WAINWRIGHT, JMP.
Gobind Singh has documented 26 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on IMUX, Immunic at 19-Sep-2022.
Analyst best performing recommendations are on EVLO (EVELO BIOSCIENCES).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) on 5/24/2021. The price target of $48 was fulfilled within 57 days with a profit of $12.69 (35.94%), with a performance score of 6.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$2
$80
3 years 3 months 27 days ago
(26-Jul-2023)
1/2 (50%)
$-5.88 (-74.62%)
83
Buy
$10
$10
3 years 8 months 5 days ago
(17-Mar-2023)
2/2 (100%)
$4.82 (93.05%)
79
Buy
$280
3 years 9 months 21 days ago
(01-Feb-2023)
1/3 (33.33%)
$120.6 (75.66%)
6
Buy
$41.5
5 years 20 days ago
(02-Nov-2021)
1/1 (100%)
$-162.5 (-79.66%)
190
Stocks Gobind Singh covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.